echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Lancet Neurology: Adult Bureau Of Eclampsia Risk Prediction: A Developmental and Verification Study

    Lancet Neurology: Adult Bureau Of Eclampsia Risk Prediction: A Developmental and Verification Study

    • Last Update: 2021-02-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Epilepsy is a chronic disease in which neurons in the brain discharge sudden abnormalities, leading to transient brain dysfunction.
    the seizure is short-lived, it requires long-term treatment and can lead to severe disability.
    people with epilepsy live in an uncertain state, and the constant threat of seizures has implications for personal safety, independence and mental health.
    Over the past decade, comprehensive evidence from chronic electro-encephalogram (cEEG) studies has shown that brain activity in people with epilepsy is strongly cyclical, lasting several hours (circadian rhythms) and days (many days and nights).
    this study hypothesically used these cycles to estimate the probability of future seizures, and the researchers tested the feasibility of predicting seizures in advance.
    In this paper, the authors' team conducted a retrospective analysis of cEEG data recorded using implants in patients with drug-resistant agency epilepsy (age ≥18) who were followed up at 35 U.S. centers between January 19, 2004 and May 18, 2018.
    require patients to have 20 or more electrograph seizures (development queues) or self-reported seizures (verification queues).
    the device records epileptic activity (IEA; ≥6 months of continuous hourly data) in all patients), where fluctuations help to estimate different seizure risks.
    This study developed a point-process statistical model for the initial portion of cEEG data (two queues) for each patient to form a prediction of the probability of seizures, which was tested on subsequently not observed seizure data and evaluated against an alternative time series.
    result of this is that the forecast shows the percentage of patients (IoCs) with improved opportunities.
    the study screened 72 and 256 patients, respectively, and included 18 and 157 of them in the development and validation queues, respectively.
    in 15 patients (83%) in the development queue and 103 (66%) in the validation queue, the model combined information from multiple IEA cycles and generated a seizure prediction for the next date through the IoC.
    61 (39%) out of 18 patients (11%) and 157 patients were extended to three days while maintaining the IoC.
    predicting a shorter 1-hour range (which may only apply to electrograph seizures in development queues) shows that all 18 (100%) patients have IoCs.
    , the results of this paper confirm a new view that seizures are not entirely random events.
    Proix, Timothée et al. Forecasting seizure risk in adults with focal epilepsy: a development and validation study. The Lancet Neurology, Volume 20, Issue 2, 127 - 135MedSci Original Source: MedSci Original Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Met Medical" or "Source: MedSci Original" are owned by Mets Medical and are not authorized to reproduce, and any media, website or individual must indicate "Source: Mays Medicine" when they are reproduced.
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    at the same time reproduced content does not represent the position of this site.
    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.